Farther Finance Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.7K Buy
1,180
+520
+79% +$11.8K ﹤0.01% 3672
2026
Q1
$13.7K Sell
660
-17
-3% -$354 ﹤0.01% 3914
2025
Q4
$14.5K Buy
677
+439
+184% +$9K ﹤0.01% 3653
2025
Q3
$3.99K Buy
238
+52
+28% +$779 ﹤0.01% 3859
2025
Q2
$2.67K Sell
186
-351
-65% -$4.81K ﹤0.01% 3599
2025
Q1
$7.79K Buy
+537
New +$7.63K ﹤0.01% 2856
2024
Q2
Sell
-43
Closed -$419 3888
2024
Q1
$419 Sell
43
-257
-86% -$2.39K ﹤0.01% 3070
2023
Q4
$2.79K Buy
300
+284
+1,775% +$2.94K ﹤0.01% 2281
2023
Q3
$203 Hold
16
﹤0.01% 2461
2023
Q2
$227 Hold
16
﹤0.01% 2343
2023
Q1
$239 Hold
16
﹤0.01% 2176
2022
Q4
$238 Buy
+16
New +$261 ﹤0.01% 1999

Other funds holding MD

Farther Finance Advisors's MD Position: Q2 2026 in Review

Farther Finance Advisors increased its Pediatrix Medical (MD) stake by 79% in Q2 2026, buying an estimated $11.8K and bringing the position to 1,180 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3672.

Farther Finance Advisors first reported a position in MD in Q4 2022 and has held it in 12 quarters since. 44 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Farther Finance Advisors held 1,180 shares of Pediatrix Medical worth $29.7K as of Q2 2026.
  • Farther Finance Advisors bought 520 Pediatrix Medical shares in Q2 2026, an estimated $11.8K.
  • Pediatrix Medical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3672 holding.
  • Farther Finance Advisors first reported a position in Pediatrix Medical in Q4 2022 and has held it in 12 quarters since.
  • 44 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.